Kiniksa Pharmaceuticals is a privately-held biotechnology company, focused on developing and delivering therapeutics for patients with devastating diseases and unmet medical needs. The company has a pipeline of programs across various stages of clinical and preclinical development.
Kiniksa has significant financial capital and a clear vision of building a generational company. Our unwavering commitment to patients is fulfilled through our Drive, Energy and Passion. Every Second Counts!
Kiniksa is also actively looking to acquire or in-license additional programs and technologies across all stages of development.